JAMIE FUHRER: Open Payments
NPI 1679738124 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 32 payments from 9 companies in 2025. Trend: 2023 $276 · 2024 $354 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $177 |
| Alkermes, Inc. | 4 | $159 |
| Axsome Therapeutics, Inc. | 3 | $90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Corium, LLC | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $15 |
Products named: VRAYLAR, LYBALVI, Auvelity, CAPLYTA, Azstarys, INGREZZA, AUSTEDO XR, REXULTI.
Industry payments across PA — which companies pay providers there.
